SLT Holdings »

Bioxcel Therapeutics shares owned by SLT Holdings

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by SLT Holdings from 13F filings

Historical chart of SLT Holdings investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by SLT Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by SLT Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $76k 30k 2.56

More positions owned by SLT Holdings

NVIDIA Corporation (NVDA)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Apple (AAPL)
Microsoft Corporation (MSFT)
D-wave Quantum (QBTS)
Tesla Motors (TSLA)
Broadcom (AVGO)
Amazon (AMZN)
Arqit Quantum *w Exp 09/03/202 (ARQQW)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Zscaler Incorporated (ZS)

View all positions for SLT Holdings

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
FMR
Vanguard Group
Geode Capital Management
XTX Topco
BlackRock
State Street Corporation
UBS Group
Oaktree Fund Advisors
Northern Trust
Jones Financial Companies, L.L
HighTower Advisors
Foundations Investment Advisors
SLT Holdings

View all funds holding Bioxcel Therapeutics